Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis

Launched by XIJING HOSPITAL · Jan 19, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called transcutaneous electrical acustimulation for people with mild to moderate ulcerative colitis, a condition that causes inflammation in the intestines. The study aims to see if this treatment can help improve symptoms and ensure it is safe for patients. If you are an adult aged 18 or older and have been diagnosed with ulcerative colitis for at least three months, you might be eligible to participate. It's important that you have tried at least one type of medication for your condition but didn’t find it helpful.

If you join the study, you can expect to receive this treatment, which involves using a special device that sends electrical signals through the skin to help manage your symptoms. The researchers will monitor your health closely throughout the trial to see how well the treatment works and if there are any side effects. However, please note that people with severe ulcerative colitis, those who have had recent surgeries, or those who are pregnant or breastfeeding cannot participate. This trial is currently recruiting participants, so it could be a good opportunity to explore a new treatment option for your condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Age ≥18 years
• • 2. Ulcerative colitis diagnosed for at least 3 mouths.
• • 3. Mayo score 4-10, Mayo endoscopic score 2-3 points
• • 4. Resistant to at least one type of medical treatments
• Exclusion Criteria:
• • 1. Treatment-naive ulcerative colitis (no previous treatment)
• • 2. Acute severe ulcerative colitis
• • 3. Previous surgical treatment or severe colitis at imminent risk of surgery infective colitis
• • 4. Other systemic diseases
• • 5. Pregnancy and lactation
• • 6. Allergic to the electrode patch